Rise in late-stage prostate cancer raises concerns over testing
About this episode
Late-stage prostate cancer diagnoses are on the rise in Canada. According to a recent study, between 2010 and 2021, rates of prostate cancer discovered at Stage 4 increased by about 50 per cent in men aged 50 to 74. In men over the age of 75, rates were up over 65 per cent.
There is a simple blood test that can screen for early signs of prostate cancer, called a prostate specific antigen, or PSA test; however, in 2014, Canada recommended against using the PSA for widespread screening. Today, Globe health reporter Kelly Grant explains what this study found and why these guidelines are so highly contested in Canada.
Questions? Comments? Ideas? Email us at [email protected]
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.
Get every episode summarized
Each time The Decibel publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from The Decibel
How much AI music is in your playlist?
The Decibel
What war in Iran means for Canadian oil
The Decibel
Why holding government to account in Ontario could get harder
The Decibel
Behind schedule and over budget: Why do we keep building LRTs?
The Decibel